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An innovative delivery system based on bacteriophages-loaded alginate-nanohydroxyapatite hydrogel was developed as a multifunctional
approach for local tissue regeneration and infection prevention and control. Bacteriophages were efficiently encapsulated, without
jeopardizing phage viability and functionality, nor affecting hydrogel morphology and chemical composition. Bacteriophage delivery
occurred by swelling-disintegration-degradation process of the alginate structure and was influenced by environmental pH. Good tissue
response was observed following the implantation of bacteriophages-loaded hydrogels, sustaining their biosafety profile. Bacteriophages-
loaded hydrogels did not affect osteoblastic cells' proliferation and morphology. A strong osteogenic and mineralization response was
promoted through the implantation of hydrogels system with nanohydroxyapatite. Lastly, bacteriophages-loaded hydrogel showed excellent
antimicrobial activity inhibiting the attachment and colonization of multidrug-resistant E. faecalis surrounding and within femoral tissues.
This new local delivery approach could be a promising approach to prevent and control bacterial contamination during implantation and bone
integration.
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2 J.A.R. Barros et al / Nanomedicine: Nanotechnology, Biology, and Medicine 24 (2020) 102145Graft implantation is the most used technique for bone loss
repair and augmentation, in orthopedic surgical approaches.1
However, the implantation procedure is highly susceptible to
bacterial infection, due to either locally recruited microorgan-
isms or hematogenous spread of existing pathogens.2, 3 Current
curative approaches, as surgical debridement and prolonged
systemic antibiotic therapy often translate into high risk of life-
long functional impairment and morbidity and contribute to
increasing economic burden in healthcare systems.3–5 Local
strategies as vehicles for antimicrobial agents delivery has
emerged as an adjunct in the prevention and treatment of bone
graft-related infections.3, 6–8 Local delivery systems show
advantages over systemic approaches, such as drug delivery at
or close to the infection site, increased efficacy and bioavail-
ability of the antimicrobial agent, dose reduction and decreased
systemic toxicity risks.8 However, some limitations are associ-
ated to these systems, namely delivery of sub-therapeutic
antimicrobial levels, favoring bacterial resistance development;
limited antimicrobial diffusion into the peri-implant tissues;
dose-dependent antimicrobial activity, and potential cytotoxicity
of the antimicrobial agents.8, 9 Indiscriminate use of antibiotics
has vastly contributed to the emergence of antibiotic-resistant
bacteria, increasing its pathogenicity leading to defaulting
treatment of infections caused by them.10, 11 To overcome
such limitations, new therapeutics are urgently needed.
Bacteriophages (phages) have emerged as an alternative
approach to current antimicrobial chemotherapy due to their
capacity to infect and kill specific bacterial strains, without
modifying the established commensal microbiome.9, 10, 12–15
Phages are virulent viruses that recognize specific receptors in
bacteria, injecting their genetic material and using the host
biochemical machinery to replicate new phages' particles and
enzymes, responsible for subsequent bacterial lysis. Further-
more, newly formed phages particles are released spreading and
infecting other target bacteria nearby.10, 16 Phages’ propagation
and persistence always depend on its host bacterial pathogen
presence, contributing to regulate phages number in direct
relation with pathogen level facilitating diffusion into surround-
ing areas in a gradient directly dependent on pathogen
availability.9, 10, 12 Likewise, phages are not pathogenic for
eukaryotic cells. Despite being able to interact with phagocytic
cells and be adsorbed through mammalian cells’ surface
receptors, being subsequently phagocytosed and degraded,
they are not threatening.10, 12, 17
Several studies have explored the potential of systemic phages
administration for the treatment of implant-related infections.13–15,
18–21 Nonetheless, experimental studies using phages-loaded
biomaterials for local delivery approaches are scarce,9, 22, 23
focusing on the phages release and antimicrobial activity, without
simultaneously exploring the potential combination with a
regeneration inductive biomaterial. Therefore, this work aims to
develop amulti-functional regenerative biomaterial for local phage
delivery, based on an alginate-nanohydroxyapatite (Alg-nanoHA)
hydrogel system. To the best of our knowledge, the present work is
novel in addressing phage-loaded biomaterials as a novel local
delivery system, simultaneously promoting bone tissue regenera-
tion, and preventing local tissue infections. The efficacy and safety
of this new system were evaluated in vitro, ex vivo and in vivo.Methods
Hydrogel system preparation and physico-chemical character-
ization
Initially, phages-free hydrogels (Alg and Alg-nanoHA) were
prepared, that were used as controls. Briefly, a 2% (w/v) alginate
solution (Alg) was obtained by dissolving sodium alginate powder
in distilled water, at room temperature. This solution was mixed
with nanoHA powder (nanoXIM.HAp202, FLUIDINOVA®) at
30 wt%, during 1h at 60 rpm. After homogeneity, mixture was
dropped into a 250mM calcium chloride (CaCl2) solution and was
allowed to harden for 30 min. Afterward, hydrogels were rinsed
twice with PBS and kept at 4°C. To disclose the relevance of
nanoHAwithin the hydrogel system, Alg hydrogels were similarly
prepared, but in the absence of nanoHA.
Following, E. faecalis phages vB_EfaS_LM99 (LM99),
previously described by Barros et al.,24 were encapsulated into
hydrogels. Phages LM99 solution (108 PFU/mL) was suspended
in the Alg and Alg-nanoHA solutions. Then, Alg + phage LM99
and Alg-nanoHA + phage LM99 mixtures were dropped into a
crosslinking solution to obtain hydrogels, under the same
conditions as above mentioned.
Phages-loaded hydrogels structure was observed by scanning
electronmicroscopy (SEM). Sampleswere coatedwith a thin gold-
palladium layer (SPI-Module) in an argon atmosphere and
examined using an FEI Quanta 400FEG/ESEM microscope.
Phages-freeAlg andAlg-nanoHAhydrogels were used as controls.
Phages-loaded hydrogels were further observed by transmis-
sion electron microscopy (TEM). Briefly, samples were fixed in
2.5% glutaraldehyde and 2% paraformaldehyde in cacodylate
Buffer 0.1M (pH7.4), dehydrated and embedded in Epon resin.
Ultrathin sections were prepared and stained with uranyl acetate
and lead citrate for 15min each and examined under a JEOL/JEM
1400 microscopy (TEM). Images were digitally recorded using a
CCD digital camera Orious 1100W. Phages-free Alg and Alg-
nanoHA hydrogels were used as controls.
Chemical characterization of phages-loaded hydrogels was
performed using attenuated total reflectance – Fourier trans-
formed infrared spectroscopy (ATR – FTIR), using a Perkin –
Elmer 2000 FTIR spectrometer. The samples were analyzed at a
spectral resolution of 2 cm−1 and 100 scans were accumulated
per sample. Phages-free Alg and Alg-nanoHA hydrogels were
used as controls.
Functional characterization
Encapsulation efficiency of the phages and hydrogel system
shelf-life assessment
To evaluate the efficiency of phages’ encapsulation, phages-
loaded hydrogels were dissolved in a microsphere-broken
solution (MBS) containing 50 mM sodium citrate, 0.2 M sodium
bicarbonate, and 50mM Tris-HCl, pH7.5, for 3 h under shaking
at room temperature. Stability of phage LM99 in MBS was
previously tested and validated. Phages encapsulation was
quantified by the double-agar-layer plating method25 and
expressed in PFU/mL. Encapsulation efficiency (EE) was
calculated as described elsewhere.26 The encapsulated phages
shelf-life was tested in Alg and Alg-nanoHA solutions, before
Figure 1. (A) SEM micrographs of nanoHA dispersed through Alg matrix. Scale bar 1mm and 50 μm. (B) TEM micrographs of Alg network and of (C) phages
structures-free hydrogels and encapsulated into hydrogels. Scale bar 200 nm.
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solutions stored at 4°C, and after the dissolution of hydrogels
in MBS, the phages titer was quantified and expressed in PFU/
mL plotted against time. Three independent experiments were
performed in triplicate.
Effect of pH on the structural behavior of hydrogels and
influence on phages release
The effect of pH on the swelling behavior of the hydrogels and
associated phages release was determined by the quantification of
the swelling ratio and phages titer after 24 h. The hydrogels
swelling behavior was evaluated and calculated by measuring the
changes in sample weight as a function of sample incubation in
PBS at 37°C, for 24 h, as described in the literature.27 Alg andAlg-
nanoHA hydrogels phages-free were used as controls. The phages
released from hydrogels were quantified by the double-agar-layer
plating method and expressed in PFU/mL. The results were taken
as the mean values of eight measurements. The experiments were
performed in triplicate.
Profile of phages LM99 release
The profile of phages release from the hydrogels was assayed
under dynamic conditions in PBS at 150 rpm and 37°C. At pre-
determined time points, cumulative released phages were
quantified using the double-agar-layer plating method. The
cumulative amount of released phages was plotted against time.
Three independent experiments were performed in triplicate.
Biological characterization
Inflammatory response – in vivo subcutaneous tissue implantation
The experiment was approved by the Local Ethics Committee
and the national regulatory entity – Direção Geral deAlimentação e Veterinária (DGAV), observing the technical
standards of protection for experimental animals, according to
both policies and principles of laboratory animal care and with
the European Union guidelines (European Directive 2010/63/EU
and National Decree-Law 113/2013). Housing, anesthesia, and
post-operative care were performed according to Silva et al.7
Sixteen New Zealand white rabbits, 18 weeks old and weighing
between 3700-3900 g, were used for the subcutaneous
implantation of the phages-loaded hydrogels. Briefly, a cutane-
ous incision (about 3 cm long) was performed in the dorsal
region for the implantation of hydrogels following blunt
subcutaneous dissection. Hydrogels were randomly implanted
and after hemostatic control, the surgical wound was terminated
with Polyglactin 910-4/0 restorable suture, with single stitches.
In each animal, three hydrogels were implanted. Two and six
weeks after implantation, the animals were euthanized with an
anesthetic overdose. The subcutaneous tissue with hydrogel
implants was collected by debridement and fixed for conven-
tional histological preparation. Tissue samples were included in
paraffin and, following section, stained with hematoxylin and
eosin (H&E). Histological analyses were performed following
image acquisition with an Olympus BX-51/22 dotSlide digital
virtual microscope. Phages-free Alg and Alg-nanoHA hydrogels
were used as controls.
Osteogenic response
In vitro cytocompatibility assessment with human osteoblastic
cells
In vitro cytocompatibility of phages-loaded hydrogels was
studied using human osteoblast-like cells (MG63), following cell
culture characterization in the presence of hydrogels’ eluents.
These were collected under dynamic conditions, following
Figure 2. (A) ATR–FTIR spectra of the hydrogels. (B) Encapsulation efficiency of phages on hydrogels. (C, D) Phages titer into solutions and hydrogels,
respectively. Quantitative data are expressed in mean ± SD.
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MEM), for 24 h, at 37°C, and at 150 rpm. Phages-free Alg and
Alg-nanoHA hydrogels were used as controls. Culture medium
without hydrogels was used as a reference control.
Cell cultures were grown in α-MEM supplemented with 10%
fetal bovine serum (FBS), 2.5 μg/mL amphotericin B, 100 IU/
mL penicillin and 100 μg/mL streptomycin at 37°C, in a
humidified atmosphere of 5% CO2 in the air. For sub-culture,
adherent cells were enzymatically released with 0.05% trypsin in
0.25% EDTA, for 5 min at 37°C. and seeded at 104 cells/cm2.
After 24 h, cells were exposed to hydrogels’ eluents for up to
seven days. Biologic response was evaluated in terms of cell
morphology, metabolic activity and alkaline phosphatase (ALP)
activity.
At each time-point, cultures’metabolic activity was evaluated
using the MTT assay, based on the reduction of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to a pur-
ple formazan product by viable cells, as previously described.28
ALP activity was determined as described in literature.28
ALP results were normalized to total protein content and
expressed as nanomoles of p-nitrophenol produced per micro-
gram of protein. Total protein content was quantified using the
DC protein assay Kit (BioRad).
Cell cytoskeleton filamentous actin (F-actin) organization and
the osteoblastic cells morphology were assessed by immunoflu-
orescence imaging. Cells were washed with PBS and fixed with3.7% paraformaldehyde for 15 min. Following cells’ perme-
abilization with 0.1% (v/v) Triton X-100, nonspecific binding
sites were blocked with 1% bovine serum albumin for 30 min. F-
actin was stained with Alexa-Fluor 488 phalloidin-conjugated
antibody (1:100, 30 min), and nucleus counterstaining with
DAPI (1 μg/mL, 10 min). Images of fluorescent-labeled cells
were obtained with a Celena S digital imaging system (Logos
Biosystems). Three independent experiments were performed in
quadruplicates.
Bone formation ex vivo functional assessment
Osteogenic tissue response was assayed via ex vivo within an
embryonic chick femoral segmental defect model. This exper-
iment was carried out in accordance with guidelines and
regulations laid down in the Animals (Scientific procedures)
act 1986 and with Home office approval UK (Project license –
PPL30/2762). Femurs were dissected from 11 day-old chick
embryos (Gallus domesticus) and cut at middle diaphysis for the
establishment of a segmental defect. Then, phages-loaded
hydrogels were implanted within the produced defects and
were carefully placed into NetwellTM Insert in six-well-plates.
Femurs, with implanted hydrogels, were kept for 11 days in
minimum essential medium (α-MEM), containing ascorbic acid
(50 μg/mL), penicillin (100 U/mL)/streptomycin (100 μg/mL)
and 2.5 μg/mL amphotericin B, at the liquid/gas interface, in a
humidified atmosphere of 5% CO2 in air, and 37°C. Culture
Figure 3. (A) Effect of pH on swelling behavior and associated phages released from hydrogel system. (B) Kinetics of phages released from the hydrogel system.
Quantitative data are expressed in mean ± SD. *Significant differences between the amount of phages released over time, for same sample (Alg or Alg-nanoHA)
(P b 0.05).
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femurs were washed twice in PBS and fixed in 4% paraformal-
dehyde. Histological analyses were performed following Alcian
blue/Sirius red (AB/SR), von Kossa and Masson's trichrome
staining. Images were captured with an Olympus BX-51/22
dotSlide digital virtual microscope. Phages-free Alg and Alg-
nanoHA hydrogels were used as controls. Three independent
experiments were performed in quadruplicates.Antimicrobial activity
In vitro characterization over planktonic and sessile bacteria
Antimicrobial activity of the hydrogel system was studied
against pathogenic multidrug-resistant E. faecalis 201, obtained
from orthopedic implant-related infections.24 Exponential bac-
terial cultures (107 CFU/mL) were incubated with the hydrogels
at 37°C, 150 rpm for 24 h. After incubation, the planktonic and
sessile population (on hydrogels and on tissue culture plates
(TCPs)) were quantified by the colony-forming units’ (CFUs)
method. Bacterial growth percentage was plotted against time.
Phages-free Alg and Alg-nanoHA hydrogels were used as
controls. Three independent experiments were performed in
triplicate.Ex vivo antimicrobial assay in bacteria-infected femoral model
The antimicrobial activity was also evaluated through ex vivo
chicken femoral model. Embryonic femurs with established
defect margins were contaminated with multidrug-resistant E.
faecalis 201 (106 cell/mL), for 10min, at room temperature.
Then, phages-loaded hydrogels were implanted in the contam-
inated femurs and were carefully placed into NetwellTM Insert
in six-well-plates. After 48h of incubation, the bacterial
colonization was characterized by histological analysis following
Gram staining. Additionally, at 24 and 48 h, the planktonic
populations were quantified by CFUs method, plotting bacteria
growth percentages against time. Phages-free Alg and Alg-
nanoHA hydrogels were used as controls. Three independent
experiments were performed in quadruplicate.Statistical analysis
Experimental data were analyzed using IBM® SPSS®
Statistics (vs.22.0, SPSS, USA). Results were reported as the
mean ± standard deviation. One-way analysis of variance
(ANOVA) followed by post hoc Tukey HSD multiple
comparison tests were used to determine significant differences
(Pb0.05).
Figure 4. Histological images of subcutaneous tissue with implanted hydrogels stained with hematoxylin (the cell nucleic in blue) and eosin (extracellular matrix
and cytoplasm in pink), at 2 and 6 weeks of implantation. Scale bars 100 μm.
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Hydrogel system physico-chemical characterization
Figure 1 shows the hydrogel system structure and network
organization. Regardless of the encapsulated phages, Alg
hydrogels showed a smooth surface, whereas Alg-nanoHA
showed a rougher one. NanoHA were well embedded and
homogeneously dispersed within the polymeric matrix (Figure
1A). All samples showed a typical Alg matrix, a network of
fibril-like structures, (Figure 1B). The phages LM99 were
entrapped within the Alg matrix (Figure 1B), for both Alg and
Alg-nanoHA hydrogels. The integrity of phages’ structure
(icosahedral head and long-tail) was maintained after encapsu-
lation, as observed in Figure 1C.
The ATR–FTIR spectra (Figure 2A) show the hydrogel
system chemical composition. Regardless of phages encapsula-
tion, Alg hydrogel displayed carboxylic group (COO–) at 1592
and 1417cm-1, and hydroxyl group (OH–) between 3311 to 3307
cm-1. The bending of the OH- group of the carboxyl is depicted
at 819cm-1. ATR–FTIR spectra for phage-free and phage-loaded
Alg-nanoHA hydrogels were also similar. These presented the
peaks corresponding to the Alg matrix (COO– bands), at the
same wavelengths described for Alg hydrogels (Figure 2A).
Peaks corresponding to phosphate group (PO4
3-) were observed at
1020 cm-1 and 559 cm-1, attributed to the overlapping of COO-
stretching of Alg and PO4
3- stretching of nanoHA. The presence
of bands at 3365 cm-1 and 629 cm-1 were assigned to OH–
group, corresponding to lattice water (Figure 2A).
Functional characterization
Phages encapsulation efficiency and hydrogel system shelf-life
assessment
High amount of phages LM99 was encapsulated in Alg and
Alg-nanoHA hydrogels, with around 8.1log10 PFU/mL, support-
ing a mean phage encapsulation efficiency of 91% (Figure 2B).The encapsulation did not cause detrimental effects in phages’
activity and replication ability.
The shelf-life of encapsulated phages LM99 in solutions
(Figure 2C), and in hydrogels (Figure 2D) was studied over time.
In solution, phages titer remained constant (8.3log10 PFU/mL)
over 60 days, without alteration in phages’ stability and viability
between Alg and Alg-nanoHA solutions (Figure 2C). Regarding
hydrogels, the amount of viable phages was also found to be
broadly constant (6.9log10 PFU/mL) during 7-days, without
differences between Alg and Alg-nanoHA (Figure. 2D).
Effect of pH on swelling behavior and associated phages
release from the hydrogel system
The effect of different pH values in hydrogels’ swelling
behavior (Figure 3A1) and consequent phage release (Figure
3A2) is shown in Figure 3A. Regardless encapsulated phages,
under acidic conditions, the protonation of the COO– groups of
the Alg network occurs, promoting hydrogels shrinkage. Under
alkaline conditions occurs the ionization of the COO– groups,
endorsing the swelling of the hydrogels (Figure 3A1). A
correlation between the swelling ratio (Figure 3A1) and released
phages (Figure 3A2), was established (Figure 3). At pH3,
shrinkage of Alg and Alg-nanoHA hydrogels matrix was
observed (Figure 3A1), and no phages were detected (Figure
3A2). Increasing pH, progressive swelling behavior was
observed, with disintegration occurring at alkaline pH values
(Figure 3A1). At pH5, the swelling ratio was 130% (Figure
3A1), allowing the release of 40% of the encapsulated phages in
both hydrogels (Figure 3A2). At pH7, the swelling ratio was
230% and 95% of encapsulated phages were released from both
hydrogels (Figure 3A). Finally, at pH9, breakdown of the Alg
hydrogels was observed, while Alg-nanoHA30 continued to
swell. The released phages titer from Alg-nanoHA at pH9 was
95% (Figure 3A2). Overall, LM99 phages showed higher
stability in the pH range 5-9, with a 100% survival rate, while,
at pH3 phages were completely inactivated.
Figure 5. (A) Cell metabolic activity and (B) ALP activity of osteoblastic cells exposed to hydrogels eluents. Quantitative data are expressed in mean ± SD. (C)
Immunofluorescent images of osteoblastic cells exposed to hydrogels' eluents. The cytoskeleton was stained green and the nucleus counterstained in blue. Scale
bar 100 μm.
7J.A.R. Barros et al / Nanomedicine: Nanotechnology, Biology, and Medicine 24 (2020) 102145Profile of phages LM99 release
In Figure 3B the profile of phages LM99 release from
hydrogels is shown. No differences in released phages titer
between Alg and Alg-nanoHA hydrogels were observed over
time. A gradual increase in the phage titer was observed for 24 h.
After 30 min, 40% of encapsulated phages were released and
after 6 and 24 h of incubation, 88% and 97% of phages were
released, respectively. After this time point, no differences were
observed in the amount of phages, with almost all phages being
released from Alg and Alg-nanoHA hydrogels (Figure 3B).
Biological characterization
Inflammatory response – in vivo subcutaneous tissue implanta-
tion
Throughout the follow-up period, no post-operative compli-
cations as tissue infection or other adverse host reactions were
identified (Figure 4). At the defined time points, animals were
euthanized and a systematic necropsy was carried out, revealing
no macroscopic alterations of internal organs. Also, at the
implantation site, no significant inflammatory reaction or cellular
exudate was identified.
After 2 weeks, tissue surrounding implanted hydrogels,
phages-free and phages-loaded, displayed symptoms of a mild
immune activation. Moreover, all implanted hydrogels were
surrounded by a capsular organized structure, rich in fibroblasts
and collagen fibers. The cells population within the hydrogels at
two weeks consisted mainly of polymorphonuclear leukocytes,
lymphocytes, and macrophages, with no evidence of bleeding,
intercellular edema, or vascular congestion (Figure 4). Compar-
atively, no differences in the immune response, recruited cell
populations, and tissue infiltration were observed between all
conditions at six weeks, while an increased hydrogel fragmen-
tation was observed, with tissue infiltration established through-
out the fragments of the implanted hydrogels. Again, no phageencapsulation was found to modify the obtained cell response on
Alg and Alg-nanoHA hydrogels (Figure 4).
Osteogenic response
In vitro cytocompatibility assessment with human osteoblastic
cells
An increase in MTT reduction values was observed in the
control, throughout the 7-days culture period. Comparatively, no
significant differences were found between cells exposed to
hydrogels eluents, phages-free or phages-loaded, and no
differences were found between them and the reference control
(free-hydrogel eluents) (Figure 5A).
Functional activity of grown osteoblastic cultures, determined
by ALP activity, was found to increase between days 3 and 7 of
culture, with highest levels being obtained at day 7, in cultures
grown on control (Figure 5B). Cultures grown in the presence of
hydrogels eluents, phages-free or phages-loaded, presented
similar results, and no significant differences were found
between the several conditions (Figure 5B).
Cells massively adhered to culture substrates, presenting an
elongated and spread morphology with evident cell-to-cell contact
being established since day 1 (Figure 5C). Cells further exhibited
well-organized F-actin cytoskeletons and prominent central nuclei,
with philopodia extending at the cell margins. Representative
images at day 3 revealed an active proliferation, which further
increased until day 7,when organized cell layers could be depicted,
with highly confluent zones. The cells exposed to hydrogels
eluents, phages-free or phages-loaded, showed similar morpho-
logical organization within the reference cultures.
Ex vivo functional assessment of bone formation
Phages-free and phages-loaded Alg hydrogels induced a
moderate osteogenic activation at the margin of the established
segmental defect, and also at the bone collar formed within the
Figure 6. Histological analysis of embryonic femurs implanted with hydrogels. Segmental defect region of the femur in contact with the hydrogel that was lost
during histological preparation. Femurs were stained with: AB/SR (proteoglycan cartilage in blue and collagen production in red); Masson's trichrome (collagen
fibers in blue), and van Kossa (bone mineralization in black). Scale bar at 200 μm.
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increased osteogenic response was observed for Alg-nanoHA
hydrogels, regardless the presence of phages. The implantation
of Alg-nanoHA enhanced significantly collagenous matrix
deposition within the central and marginal regions of the
diaphysial structure and an organized and thick trabecular
structure was formed. Masson’s trichrome staining further
corroborated increased collagenous deposition observed with
Alg-nanoHA hydrogels. Increased mineral deposition within the
developed trabecular structure was also evidenced by the von
Kossa staining. It should be noticed that phage encapsulation
seems not to have interfered with the enhanced osteogenic
capability of Alg-nanoHA hydrogels.
Antimicrobial activity
In vitro characterization over planktonic and sessile bacteria
The antimicrobial activity of the hydrogel system against
planktonic and sessile bacteria is depicted in Figure 7.
In the presence of phages-free hydrogels, an increase in
planktonic and sessile population was observed after 24 h, and
no significant differences between Alg and Alg-nanoHA
hydrogels could be found.
In the presence phages-loaded hydrogels, planktonic bacteria
were significantly inhibited (around 99%), after 24h incubation
(Figure 7A). Regarding sessile bacteria into hydrogels and in
TCPs, the phages-loaded hydrogels showed the same antimicro-
bial behavior. Phages-loaded hydrogels were further able to
reduce the bacterial attachment in 98% on hydrogels and 92% on
TCPs. No differences in antimicrobial activity were found
between Alg + LM99 and Alg-nanoHA + phage LM99
hydrogels.
Ex vivo antimicrobial assay in bacteria-infected femoral model
Antibacterial activity was also evaluated using an ex vivo
chicken femoral model, previously infected with multi-resistant
E. faecalis 201 strain (Figure 8).In the presence phages-loaded hydrogels, bacterial density
was 3-orders of magnitude lower in terms of CFUs when
compared to phage-free hydrogels, corresponding to inhibitions
of 99.6% and 99.9% after 24 and 48 h, respectively (Figure 8A).
No differences in antimicrobial activity were found between Alg
+ LM99 and Alg-nanoHA + phage LM99 hydrogels.
Bacterial colonization within femurs was dependent on the
hydrogels implanted within a segmental defect (Figure 8B).
Regarding phages-free hydrogels implantation, bacterial colo-
nies were identified within the femurs tissue structure (Figure 8B
– a.2, a.2.1, a.2.2, b.2, b.2.1 and b.2.2), as revealed by Gram
staining. Contrariwise, no bacterial growth was noticed when
phages-loaded hydrogels were implanted (Figure 8B – c.2, c.2.1,
c.2.2, d.2, d.2.1 and d.2.2).Discussion
Any surgical intervention, particularly including biomaterials
implantation, is associated to high risk of infection, which can be
devastating for the patients, generating overload healthcare
systems.29 Antimicrobial-loaded biomaterials, as delivery sys-
tems, have received special attention in applications for
prevention and treatment of implant-related infections.9, 29
However, limited antimicrobial diffusion, sub-therapeutic levels
of antimicrobial agent, dose-dependent antimicrobial activity,
antimicrobials’ toxicity, and the spread of antibiotic-resistant
bacteria, underscore the need for new approaches to control these
bacterial infections.6, 7, 9, 30
In this study, a newdrug-delivery systembased on encapsulated
phages on Alg-nanoHA hydrogels was assessed as a multifunc-
tional approach. This system has three components with specific
and complementary functionalities: 1) Alg hydrogel is responsible
for transporting and delivering the therapeutic agents to the local
target, 2) osteo-regeneration stimulation is endorsed by the
presence of bioactive and osteoconductive nanoHA, and, 3)
Figure 7. In vitro antimicrobial activity: (A) Planktonic E. faecalis 201 growth in the presence of hydrogels; (B) Sessile bacteria on hydrogels, and (C) Sessile
bacteria on TCPs. Quantitative data are expressed in mean ± SD. *Significant differences of bacterial density between phages-free and phages-loaded hydrogels,
for same sample (Alg or Alg-nanoHA) at 6 and 24 h, respectively (P b 0.05).
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by the local delivery of phages.
In the present work, it was shown that phages were entrapped
into the three-dimensional hydrogel network, by ionic cross-
linking, without jeopardizing phage morphology, viability and
functionality. A remarkable shelf-life of encapsulated phages on
Alg or Al-nanoHA solutions was observed, whereas the shelf-
life of phages into hydrogels was also broadly unaltered up to 7
days. Other authors also reported the encapsulation of phages
FelixO1 and phages UAB_Phi20 into Alg hydrogels with similar
behavior and efficiency.26, 31 The Alg solubility capacity could
explain the phage delivering from the hydrogel system. When,
drug-loaded Alg hydrogels are exposed to an aqueous medium, a
successive progression of swelling-disintegration-erosion occurs
at the Alg network by ion-exchange with the medium, allowing
the drug to diffuse out of the hydrogel.32 Several authors have
reported the importance of pH-dependence and hydrophilic
behavior of Alg network, on drug release mechanisms.31, 33, 34
For instance, at basic pH, the swelling of Alg network occurs,
due to the ionization of the COO– groups and diffusion of Ca2+
ions from gelling sites,31, 33, 34 allowing thereby the phages
permeability. Whereas, under acid conditions the Alg network
shrinks, due to the protonation of the COO– groups and increase
of cross-linking degree,31, 33, 34 holding the phages entrapped in
Alg matrices. It should be noted that no detrimental effects on
phages viability and functionally were observed after phagesdelivery at broad range of pH 5 – 9, which could be a promising
feature for phages delivery at the site of bone infection, where the
normal pH is 6.8.35 Besides, it was shown that the presence of
nanoHA into the hydrogel system did not affect the phage
releasing from hydrogels, with almost all phages being released
from the composites, suggesting Alg-nanoHA hydrogels could
be used as a suitable phages release delivery system.31, 33, 34
Similar phages release profiles were reported from hydroxypro-
pylmethylcellulose, alginate/CaCO3 or Eudragit® hydrogels for
targeted delivery of phages.9, 23, 31, 34
Biocompatibility and safety are important requirements for
local drug delivery systems and their tissue engineering
applications.36 In the present work, good biocompatibility and
safety profiles were observed for all hydrogels subcutaneously
implanted in a rabbit model. Some reports have shown the
efficiency of phages therapy in medical, veterinary, agricultural,
and aquaculture applications without adverse safety concerns for
eukaryotic cells.13, 37, 38 Phages administration has shown to
stimulate the host immune response, depending on the route of
administration, e.g., oral and topical administrations may induce
the production of anti-phages neutralizing antibodies, while
intravenous administration of phages has the potential to
stimulate innate and adaptive immune responses.13, 39 No
significant differences were identified on the local tissue
response following the implantation of phages-loaded hydrogels,
sustaining their biosafety profile.
Figure 8. Ex vivo antimicrobial activity: (A) E. faecalis 201 density growth surrounding femurs implanted with hydrogels. Quantitative data are expressed in
mean ± SD. *Significant differences in bacterial proliferation between femurs implanted with phages-free and phages-loaded hydrogels, for same sample (Alg or
Alg-nanoHA) at 24 and 48 h, respectively (P b 0.05). (B) Histological analysis of bacterial colonization within the implanted femurs, following Gram staining.
Bacterial clusters were observed in the trabeculae (a.2.1 and b.2.1) and in the underlying spaces (a.2.2 and b.2.2) of the femoral tissues implanted with phage-
free-hydrogels (a.2 and b.2). Scale bar at 200 μm.
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phages and hydrogels’ leachable products did not interfere with
osteoblastic cells’ viability, proliferation and morphology,
indicating that the phage-loaded biomaterial systems could
allow for bone cells spreading and growth. Chung et al
suggested that incorporation of phages into tissue engineering
fibers did not interfere with cell behavior.40 The cytocompat-
ibility of Alg and nanoHA materials was previously described by
other studies.33, 41
The osteogenic response of hydrogel systems was empha-
sized by ex vivo functionality of bone formation results.
Regardless the presence of phages, the Alg-nanoHA hydrogels
implantation significantly increased the osteogenic and miner-
alization response, highlighting the potential of nanoHA as an
osteoconductive and osteoinductive agent. Other studies have
shown that nanoHA is able to enhance bone ingrowth and
accelerated bone formation within and around the implanted
material.42, 43 The ex vivo data suggest that Alg-nanoHA +
phage LM99 hydrogels could be used to improve bone tissue
regeneration at local bone defects.
To the best of our knowledge, the present work is the first to
develop a drug-delivery system based on encapsulated phages on
Alg-nanoHA hydrogel to prevent and control bacterial contam-
ination during bone implantation and integration. In the present
work, the antimicrobial activity of phage LM99 encapsulated on
Alg-nanoHA hydrogels was evaluated against multidrug-
resistant E. faecalis 201 bacteria, under both in vitro and ex
vivo conditions, as proof of concept. Under in vitro conditions,
effective antimicrobial activity and large diffusion of phages
LM99 from hydrogels were observed, inhibiting attachment and
growth of planktonic and sessile E. faecalis 201 on biomaterials
and surrounding media. Besides, in ex vivo assessment, it was
shown that phage LM99-loaded hydrogels prevented prolifera-
tion and colonization of the multidrug-resistant E. faecalis 201 in
the neighborhood of the implant and within the femoral tissues.
Barros et al described the effectiveness of phage therapy in the
prophylaxis and treatment of vancomycin-resistant E. faecalis,
methicillin-resistant S. aureus (MRSA) and E. coli isolated from
orthopedic implant-related infections.24 Additionally, in the
present study, lytic phages LM1244 and JB7524 were alsoencapsulated in the developed hydrogels, and their antimicrobial
activity was evaluated in vitro against multidrug-resistant
bacteria involved in implant-related infections24 (see Supple-
mentary material). The results showed that the release of
infecting phages LM12 and JB75, to the planktonic phase, was
able to kill suspended MRSA 80 and E. coli 75, respectively
(Supplementary material). The obtained results further empha-
size the therapeutic potential of the developed local delivery
approach, in the prevention and eradication of relevant bacteria
strains, even those showing multi-drug resistance profiles, at the
implant microenvironment, prior to their adhesion and biofilm
establishment.
Overall, a new multifunctional drug-delivery system based on
encapsulated phages on Alg-nanoHA hydrogels was developed
and showed to be a promising and efficient approach to prevent
and control bacterial contamination during implantation and
bone integration.Authors' Contribution
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